Moleculin Biotech, Inc.

MBRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2019

Total Assets: $25.2M

Liabilities Breakdown FY2019

Total Liabilities: $9.7M